The University of Texas MD Anderson Cancer Center received a $125,783 Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) on June 1, 2025. The grant supports research to investigate the "Mechanisms of CDH1-Inactivated Advanced Gastric Adenocarcinoma Tumorigenesis". MD Anderson, a leading cancer research institution, will conduct this basic and translational cancer research project over a 2-year period ending on January 31, 2027. The grant funding will enable MD Anderson to advance scientific understanding of gastric cancer biology and develop new therapeutic approaches for this aggressive tumor type.
Generated 3/4/25, 8:41 AM